NCT04305925View on ClinicalTrials.gov

Focal Laser Ablation of Prostate Cancer

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

January 30, 2023

Study Completion Date

October 31, 2026

Conditions
Prostate Cancer
Interventions
DEVICE

Focal Laser Ablation

Orion system to deploy and monitor thermal energy in cancerous regions of the prostate, identified by MRI and confirmed by targeted biopsy. MRI guidance will be achieved by MRI/ultrasound fusion, overlaying stored MRI images upon real-time ultrasound images. Interstitial laser treatments would be achieved by inserting the fiber into the cancerous regions guided by the Artemis image-fusion device. Applications of laser energy up to 15 watts of power will be used to treat the target region.

Trial Locations (1)

90024

University of California at Los Angeles, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER